Moderna Inc
NASDAQ:MRNA
Moderna Inc
Retained Earnings
Moderna Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Moderna Inc
NASDAQ:MRNA
|
Retained Earnings
$12.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Retained Earnings
-$2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Retained Earnings
$10.7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
|
Amgen Inc
NASDAQ:AMGN
|
Retained Earnings
-$27.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-15%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Retained Earnings
$11.2B
|
CAGR 3-Years
95%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Retained Earnings
$28B
|
CAGR 3-Years
33%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
See Also
What is Moderna Inc's Retained Earnings?
Retained Earnings
12.4B
USD
Based on the financial report for Mar 31, 2024, Moderna Inc's Retained Earnings amounts to 12.4B USD.
What is Moderna Inc's Retained Earnings growth rate?
Retained Earnings CAGR 1Y
-32%
Over the last year, the Retained Earnings growth was -32%.